Scarica l'app Stockscreener
313.53
0.14%
0.4538
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Insulet Corporation Borsa (PODD) Ultime notizie
Truist bullish on diabetes companies citing potential market growth - MSN
Insulet’s SWOT analysis: patch pump leader’s stock poised for growth By Investing.com - Investing.com South Africa
Insulet’s SWOT analysis: patch pump leader’s stock poised for growth - Investing.com
Analyst Predicts Strong Growth for Insulet (PODD) with Buy Ratin - GuruFocus
Insider Sell: Dan Manea Sells 1,300 Shares of Insulet Corp (PODD) - GuruFocus
Insulet, EyePoint & NanoDx receive $2M in tax incentives to create life sciences jobs - Worcester Business Journal
Insulet (PODD) Rated 'Buy' by Truist Securities; Price Target Set at $365 | PODD Stock News - GuruFocus
(PODD) Investment Report - news.stocktradersdaily.com
Truist initiates Insulet stock with buy rating on diabetes pump potential - Investing.com Nigeria
Truist Initiates Insulet at Buy With $365 Price Target - MarketScreener
Truist Securities Starts Insulet Corporation (PODD) at Buy - StreetInsider
Insulet’s SWOT analysis: pump maker’s stock rides wave of growth By Investing.com - Investing.com South Africa
Insulet’s SWOT analysis: pump maker’s stock rides wave of growth - Investing.com
Here's Why You Should Retain PODD Stock in Your Portfolio Now - MSN
Insulet Boosts Its Diabetes Device Via Comical Campaign -- And A Comic Book 06/12/2025 - MediaPost
Marvel’s latest superhero: Insulet’s comic book star with type 1 diabetes - Medical Marketing and Media
Insulet, Marvel collab to unveil comic book hero with type 1 diabetes - MassDevice
Possible Bearish Signals With Insulet Insiders Disposing Stock - simplywall.st
Insulet Director Cashes In on Stock Sale! - TipRanks
Insider Sell: Luciana Borio Sells Shares of Insulet Corp (PODD) - GuruFocus
Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7 - MassDevice
Insulet at Goldman Sachs Conference: Strategic Growth and Leadership Transition - Investing.com Nigeria
Insulet Corporation's Omnipod 5 App for Iphone with Dexcom G7 Integration Now Available to All U.S. Users - MarketScreener
Transcript : Insulet Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 09 - MarketScreener
Insulet's Omnipod® 5 App For iPhone With Dexcom G7 Integration Now Available To All US Users - marketscreener.com
Insulet (PODD) Omnipod 5 App Now Compatible with Dexcom G7 on iPhone | PODD Stock News - GuruFocus
Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration N - GuruFocus
Insulet announces Omnipod 5 App for iPhone is compatible with Dexcom G7 CGM - TipRanks
Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users | PODD Stock News - GuruFocus
Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users - Business Wire
Insulet To Present At Goldman Sachs Global Healthcare Conference; Webcast At 9:20 AM ET - Nasdaq
PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption - Yahoo Finance
Insulet Corporation (PODD) Announces Credit Agreement Refinancin - GuruFocus
Insulet Corporation (PODD) Announces Credit Agreement Refinancing and Convertible Notes Redemption - GuruFocus
Insulet Issues Redemption Notice for Convertible Notes - TipRanks
Insulet enters eighth amendment to credit agreementSEC filing - MarketScreener
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today - Benzinga
3 Medical Technology Stocks Outperforming in 2025 - MarketBeat
Raindrop Injects Personality Into Omnipod 5’s Diabetes Campaign - Little Black Book | LBBOnline
Omnipod 5 Helps Make Diabetes a Smaller Part of Life In New Work From Raindrop - citybiz
TD Cowen Raises Insulet (PODD) Price Target, Maintains Buy Rating - Insider Monkey
TD Cowen raises Insulet stock price target to $379 after strong Q1 - Investing.com Nigeria
Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks - Yahoo Finance
Goldman Sachs Initiates Coverage of Insulet (PODD) with Buy Rating - MSN
TD Cowen raises Insulet stock price target to $379 after strong Q1 By Investing.com - Investing.com South Africa
Here's Why Insulet (PODD) is a Strong Growth Stock - Yahoo Finance
Insulet Corporation (PODD) PT Raised to $379 at TD Cowen After a Stellar 1Q - StreetInsider
TD Cowen Boosts Insulet (PODD) Price Target Following Strong Quarter | PODD Stock News - GuruFocus
0.91%
0.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):